Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is considered to be one of the most common chronic liver diseases across worldwide. Epigallocatechin-3-gallate (EGCG) derived from extract of green tea and is well known for beneficial effects on anti-oxidative, anti-inflammatory, and anti-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuanyuan, Yin, Ruili, Lang, Jianan, Fu, Ying, Yang, Longyan, Zhao, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006476/
https://www.ncbi.nlm.nih.gov/pubmed/35418153
http://dx.doi.org/10.1186/s13098-022-00823-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006476/
https://www.ncbi.nlm.nih.gov/pubmed/35418153
http://dx.doi.org/10.1186/s13098-022-00823-y

Ejemplares similares